Tata Chemicals Ltd. reported a 4% revenue decrease to ₹3,590 Cr for Q3FY25, with EBITDA falling 20% to ₹434 Cr, amid challenges from lower Soda Ash pricing and operational costs; however, a new 70 KTPA Pharma Salt plant was commissioned in the UK.
AI Assistant
Tata Chemicals Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.